Subgroup analysis showed that there were no statistically significant differences in priapism history, regular hydration therapy, PDE5 inhibitor use, and postoperative complications between patients with SCD-associated priapism who underwent prosthesis implantation and those who did not (p > 0.05) (Table 3). The gene discussed is PDE5A; the disease is Priapism.